Atherosclerosis and Thrombosis: Insights from Large Animal Models
Open Access
- 2 January 2011
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 907575
Abstract
Atherosclerosis and its thrombotic complications are responsible for remarkably high numbers of deaths. The combination ofin vitro, ex vivo, andin vivoexperimental approaches has largely contributed to a better understanding of the mechanisms underlying the atherothrombotic process. Indeed, different animal models have been implemented in atherosclerosis and thrombosis research in order to provide new insights into the mechanisms that have already been outlined in isolated cells and protein studies. Yet, although no model completely mimics the human pathology, large animal models have demonstrated better suitability for translation to humans. Indeed, direct translation from mice to humans should be taken with caution because of the well‐reported species‐related differences. This paper provides an overview of the availableatherothrombotic-likeanimal models, with a particular focus on large animal models of thrombosis and atherosclerosis, and examines their applicability for translational research purposes as well as highlights species‐related differences with humans.Keywords
This publication has 143 references indexed in Scilit:
- Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause modelAtherosclerosis, 2008
- Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathwayEuropean Journal of Clinical Investigation, 2008
- Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient miceThe Journal of Pathology, 2001
- Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantationJACC, 2000
- Pathobiologic Responses to Stenting 11Supported in part by grants from the National Institutes of Health (GM/HL49039 and HL03104), the Burroughs Wellcome Fund for Experimental Therapeutics, Durham, North Carolina, and the Whitaker Foundation, Rosslyn, Virginia.The American Journal of Cardiology, 1998
- The Porcine Model for the Understanding of Thrombogenesis and AtherogenesisMayo Clinic Proceedings, 1991
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator.Circulation, 1984
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?Circulation, 1982
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976